SKI Market

A+| A| A-|

Indian Indices

Sensex

76,991.22 790.54
( 1.04%)

Global Indices

Nasdaq

51,704.04 -29.67
(-0.06%)

Dow Jones

7,389.07 -104.72
(-1.40%)

Hang Seng

69,343.30 -445.08
(-0.64%)

Nikkei 225

10,454.55 16.70
(0.16%)

Forex

USD-INR

94.53 0.21
(0.22%)

EUR-INR

108.18 0.03
(0.03%)

GBP-INR

125.09 0.39
(0.31%)

JPY-INR

0.58 0.00
(0.06%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Smruthi Organics Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

540686

INE172E01011

64.2271775

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

36.33

135.98

EPS(TTM)

Face Value()

Div & Yield %

3.27

1.26

Back

Board of Dr Lal Pathlabs approves acquisition of Shahbazkers Diagnostic Centre

Apr 30,2026

The board of Dr Lal Pathlabs at its meeting held on 30 April 2026 has approved the acquisition of 100% stake in Shahbazkers Diagnostic Centre (SDCPL) from its existing Shareholders. Post acquisition, SDCPL shall become a wholly owned subsidiary of the company.

76,991.22 790.54 ( 1.04%)

51,704.04 -29.67 (-0.06%)

7,389.07 -104.72 (-1.40%)

69,343.30 -445.08 (-0.64%)

10,454.55 16.70 (0.16%)

94.53 0.21 (0.22%)

108.18 0.03 (0.03%)

125.09 0.39 (0.31%)

0.58 0.00 (0.06%)